Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

86.99 -0.60 (-0.69%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Via Benzinga
Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Via Benzinga
Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday
Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get  
Via Benzinga
NYSE:BSX may be ready to breakout.
BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
Via Benzinga
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
What 18 Analyst Ratings Have To Say About Boston Scientific
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
Via Benzinga
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings
These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023. 
Via The Motley Fool
Topics ETFs
Uncovering Noteworthy Technical Analysis Findings for BOSTON SCIENTIFIC CORP (NYSE:BSX).
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP. 
Via Chartmill
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Peering Into Boston Scientific's Recent Short Interest
Via Benzinga
3 Healthcare Stocks to Pick Up Before the Year-End Rally
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending 
Via InvestorPlace
Expert Ratings for Boston Scientific
Via Benzinga
A Look Into Boston Scientific Inc's Price Over Earnings
Via Benzinga
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Will Boston Scientific Corporation (BSX) Continue Further upside?
Boston Scientific Corporation (BSX​​​​​​​) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular... 
Via Talk Markets
Could Ozempic Harm These 3 Medical Device Stocks?
The drug is on track to cause massive competitive shifts in the healthcare sector. 
Via The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations. 
Via InvestorPlace
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
Via AB Newswire
Exposures Product Safety
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook
Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. 
Via Benzinga
Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter Beat
The company also raised its outlook for the full year. 
Via Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.